{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:26:33Z","timestamp":1793183193844,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.xphs.2023.12.025","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:29:43Z","timestamp":1704212983000},"page":"1385-1394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adaptive Dosage Strategy of Levetiracetam in Chinese Epileptic Patients: Focus on Pregnant Women"],"prefix":"10.1016","volume":"113","author":[{"given":"Yifei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2023.12.025_bib0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaneurol.2021.5487","article-title":"Antiseizure medication concentrations during pregnancy: results from the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study","volume":"79","author":"Pennell","year":"2022","journal-title":"JAMA Neurol"},{"issue":"9859","key":"10.1016\/j.xphs.2023.12.025_bib0002","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.xphs.2023.12.025_bib0003","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.025_bib0004","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/1570159X19666210211150856","article-title":"Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications","volume":"19","author":"Kaplan","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"26","key":"10.1016\/j.xphs.2023.12.025_bib0005","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMoa2008663","article-title":"Changes in seizure frequency and antiepileptic therapy during pregnancy","volume":"383","author":"Pennell","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.025_bib0006","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1212\/WNL.0000000000201348","article-title":"Association of levetiracetam concentration with seizure frequency in pregnant women with epilepsy","volume":"100","author":"Schelhaas","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.xphs.2023.12.025_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221101687","article-title":"Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide","volume":"15","author":"Nucera","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.025_bib0008","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1208\/s12248-021-00603-y","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by kidney in pregnant subjects and fetus","volume":"23","author":"Szeto","year":"2021","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.025_bib0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/epi.12109","article-title":"Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.025_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/acn3.51258","article-title":"Epilepsy risk in offspring of affected parents; a cohort study of the \"maternal effect\" in epilepsy","volume":"8","author":"Dreier","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.025_bib0011","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40262-019-00845-2","article-title":"Therapeutic drug monitoring of antiepileptic drugs in women with epilepsy before, during, and after pregnancy","volume":"59","author":"Arfman","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.025_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","article-title":"Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy","volume":"29","author":"Reisinger","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.xphs.2023.12.025_bib0013","series-title":"Bioanalytical Method Validation Guidance for Industry","author":"aDA","year":"2018"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.025_bib0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10928-015-9417-1","article-title":"Reporting guidelines for population pharmacokinetic analyses","volume":"42","author":"Dykstra","year":"2015","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.025_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00003088-200746060-00004","article-title":"Population pharmacokinetics of levetiracetam in Japanese and Western adults","volume":"46","author":"Pigeolet","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2023.12.025_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.733823","article-title":"Maternal-fetal pharmacology of drugs: a review of current status of the application of physiologically based pharmacokinetic models","volume":"9","author":"Chaphekar","year":"2021","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.025_bib0017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/FTD.0000000000000550","article-title":"Influence of sex, age, and weight on levetiracetam pharmacokinetics","volume":"40","author":"Alzueta","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.025_bib0018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40262-020-00963-2","article-title":"Population pharmacokinetics of levetiracetam: a systematic review","volume":"60","author":"Li","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.025_bib0019","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1528-1167.2008.01974.x","article-title":"Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy","volume":"50","author":"Chhun","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.025_bib0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.seizure.2007.11.027","article-title":"Serum concentration\/dose ratio of levetiracetam before, during and after pregnancy","volume":"17","author":"Westin","year":"2008","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.025_bib0021","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1528-1167.2007.01032.x","article-title":"Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation","volume":"48","author":"Tomson","year":"2007","journal-title":"Epilepsia"},{"issue":"16","key":"10.1016\/j.xphs.2023.12.025_bib0022","article-title":"Pharmacokinetic changes of levetiracetam in patients with epilepsy during pregnancy","volume":"42","author":"Ying","year":"2022","journal-title":"Chin J Hosp Pharmacy"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.025_bib0023","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/bcp.15572","article-title":"Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy","volume":"89","author":"Li","year":"2023","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T08:17:10Z","timestamp":1713169030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923005701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0022354923005701"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.025","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive Dosage Strategy of Levetiracetam in Chinese Epileptic Patients: Focus on Pregnant Women","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}